-
公开(公告)号:UA95199C2
公开(公告)日:2011-07-11
申请号:UAA201008466
申请日:2008-12-04
Applicant: VERTEX PHARMA
Inventor: KESHAVARZ-SHOKRI ALI , YOUNG CHRISTOPHER
IPC: A61K31/443 , A61P3/00
-
公开(公告)号:NZ734041A
公开(公告)日:2022-02-25
申请号:NZ73404116
申请日:2016-01-29
Applicant: VERTEX PHARMA , BIOMED VALLEY DISCOVERIES INC
Inventor: DECRESCENZO GARY , WELSCH DEAN , VLAHOVA PETINKA I , BOERRIGTER STEPHAN X M , ARONOV ALEXANDER , KESHAVARZ-SHOKRI ALI , SCANGAS ALEXANDER N , STAVROPOULOS KATHY , LITTLER BENJAMIN , KADIYALA IRINA NIKOLAEVNA , ALARGOVA ROSSITZA GUEORGUIEVA
IPC: C07D401/04
Abstract: The present invention provides crystalline forms of a compound of formula (I). Also provided are pharmaceutical compositions that include the provided crystalline forms and methods of using the provided crystalline forms and pharmaceutical compositions for the treatment of cancer. It has been discovered that crystalline forms of 4-(5-Chloro-2- isopropylaminopyridin-4-yl)-1 H-pyrrole-2-carboxylic acid [1 -(3-chlorophenyl)-2- hydroxyethyl]amide can be prepared which exhibit improved properties, e.g. surprisingly improved stability and improved solubility characteristics. Thus, the present invention provides crystalline 4-(5-Chloro-2- isopropylaminopyridin-4-yl)-1H-pyrrole-2-carboxylic acid [1 -(3-chlorophenyl)-2- hydroxyethyljamide.
-
公开(公告)号:LT3519401T
公开(公告)日:2021-11-25
申请号:LT17054611
申请日:2017-09-29
Applicant: VERTEX PHARMA
Inventor: ALCACIO TIMOTHY , BAEK MINSON , GROOTENHUIS PETER , HADIDA RUAH SARA , HUGHES ROBERT , KESHAVARZ-SHOKRI ALI , MCAULEY-AOKI RACHEL , MCCARTNEY JASON , MILLER MARK , VAN GOOR FREDRICK , ZHANG BEILI , ANDERSON COREY , CLEVELAND THOMAS , FRIEMAN BRYAN , KHATUYA HARIPADA , JOSHI PRAMOD , KRENITSKY PAUL , MELILLO VITO , PIERRE FABRICE , TERMIN ANDREAS , UY JOHNNY , ZHOU JINGLAN , ABELA ALEXANDER , BUSCH BRETT , PARASELLI PRASUNA , SIESEL DAVID
IPC: C07D401/14 , A61K31/4439 , A61P1/16 , A61P1/18 , A61P11/00 , A61P11/12 , A61P43/00 , C07D471/14 , C07D498/14
-
公开(公告)号:HRP20210165T1
公开(公告)日:2021-03-19
申请号:HRP20210165
申请日:2021-02-01
Applicant: VERTEX PHARMA
Inventor: KESHAVARZ-SHOKRI ALI , ZHANG BEILI , ALCACIO TIM EDWARD , LEE ELAINE CHUNGMIN , ZHANG YUEGANG , KRAWIEC MARIUSZ
IPC: A61K9/10 , A61K31/404 , A61P11/00 , C07D405/12
-
公开(公告)号:SI3551622T1
公开(公告)日:2021-02-26
申请号:SI201730537
申请日:2017-12-08
Applicant: VERTEX PHARMA
Inventor: ABELA ALEXANDER RUSSELL , ALCACIO TIMOTHY , ANDERSON COREY , ANGELL PAUL TIMOTHY , BAEK MINSON , CLEMENS JEREMY J , CLEVELAND THOMAS , FERRIS LORI ANN , GROOTENHUIS PETER DIEDERIK JAN , GROSS RAYMOND STANLEY , GULEVICH ANTON , HADIDA RUAH SARA SABINA , HSIA CLARA KUANG-JU , HUGHES ROBERT M , JOSHI PRAMOD VIRUPAX , KANG PING , KESHAVARZ-SHOKRI ALI , KHATUYA HARIPADA , KRENITSKY PAUL JOHN , MCCARTNEY JASON , MILLER MARK THOMAS , PARASELLI PRASUNA , PIERRE FABRICE JEAN DENIS , SHI YI , SHRESTHA MUNA , SIESEL DAVID ANDREW , STAVROPOULOS KATHY , TERMIN ANDREAS P , UY JOHNNY , VAN GOOR FREDRICK F , YOUNG TOMOTHY JOHN , ZHOU JINGLAN
IPC: C07D401/00 , A61K31/00 , A61P11/00 , C07D231/00
-
公开(公告)号:SI2826776T1
公开(公告)日:2021-02-26
申请号:SI201131935
申请日:2011-03-25
Applicant: VERTEX PHARMA
Inventor: KESHAVARZ-SHOKRI ALI , ZHANG BEILI , ALCACIO TIM EDWARD , LEE ELAINE CHUNGMIN , ZHANG YUEGANG , KRAWIEC MARIUSZ
IPC: A61K9/00 , A61K31/00 , A61P11/00 , C07D405/00
-
公开(公告)号:RS61150B1
公开(公告)日:2020-12-31
申请号:RSP20201477
申请日:2017-12-08
Applicant: VERTEX PHARMA
Inventor: ABELA ALEXANDER RUSSELL , ALCACIO TIMOTHY , ANDERSON COREY , ANGELL PAUL TIMOTHY , BAEK MINSON , CLEMENS JEREMY J , CLEVELAND THOMAS , FERRIS LORI ANN , GROOTENHUIS PETER DIEDERIK JAN , GROSS RAYMOND STANLEY , GULEVICH ANTON , HADIDA RUAH SARA SABINA , HSIA CLARA KUANG-JU , HUGHES ROBERT M , JOSHI PRAMOD VIRUPAX , KANG PING , KESHAVARZ-SHOKRI ALI , KHATUYA HARIPADA , KRENITSKY PAUL JOHN , MCCARTNEY JASON , MILLER MARK THOMAS , PARASELLI PRASUNA , PIERRE FABRICE JEAN DENIS , SHI YI , SHRESTHA MUNA , SIESEL DAVID ANDREW , STAVROPOULOS KATHY , TERMIN ANDREAS P , UY JOHNNY , VAN GOOR FREDRICK F , YOUNG TOMOTHY JOHN , ZHOU JINGLAN
IPC: C07D401/14 , A61K31/455 , A61P11/00 , C07D231/20 , C07D401/04
-
公开(公告)号:AU2020257041A1
公开(公告)日:2020-11-12
申请号:AU2020257041
申请日:2020-10-20
Applicant: BIOMED VALLEY DISCOVERIES INC , VERTEX PHARMA
Inventor: DECRESCENZO GARY , WELSCH DEAN , VLAHOVA PETINKA I , BOERRIGTER STEPHAN X M , ARONOV ALEXANDER , KESHAVARZ-SHOKRI ALI , SCANGAS ALEXANDER N , STAVROPOULOS KATHY , LITTLER BENJAMIN , KADIYALA IRINA NIKOLAEVNA , ALARGOVA ROSSITZA GUEORGUIEVA
IPC: C07D401/04
Abstract: : The present invention provides crystalline forms of a compound of formula (I): Also provided are pharmaceutical compositions that include the provided crystalline forms and methods of using the provided crystalline forms and pharmaceutical compositions for the treatment of cancer.
-
公开(公告)号:LT3170818T
公开(公告)日:2020-05-25
申请号:LT16198922
申请日:2008-12-04
Applicant: VERTEX PHARMA
Inventor: KESHAVARZ-SHOKRI ALI , ZHANG BEILI , KRAWIEC MARIUSZ
IPC: C07D405/12 , A61K31/4709 , A61P11/00
-
公开(公告)号:SG10201913595YA
公开(公告)日:2020-02-27
申请号:SG10201913595Y
申请日:2017-09-29
Applicant: VERTEX PHARMA
Inventor: ALCACIO TIMOTHY , BAEK MINSON , GROOTENHUIS PETER , HADIDA RUAH SARA SABINA , HUGHES ROBERT M , KESHAVARZ-SHOKRI ALI , MCAULEY-AOKI RACHEL , MCCARTNEY JASON , MILLER MARK THOMAS , VAN GOOR FREDRICK , ZHANG BEILI , ANDERSON COREY , CLEVELAND THOMAS , FRIEMAN BRYAN A , KHATUYA HARIPADA , JOSHI PRAMOD VIRUPAX , KRENITSKY PAUL JOHN , MELILLO VITO , PIERRE FABRICE JEAN DENIS , TERMIN ANDREAS P , UY JOHNNY , ZHOU JINGLAN , ABELA ALEXANDER RUSSELL , BUSCH BRETT BRADLEY , PARASELLI PRASUNA , SIESEL DAVID ANDREW
Abstract: Compounds of Formula I:pharmaceutically acceptable salts thereof, deuterated derivatives of any of the foregoing, and metabolites of any of the foregoing are disclosed. Pharmaceutical compositions comprising the same, methods of treating cystic fibrosis using the same, and methods for making the same are also disclosed.
-
-
-
-
-
-
-
-
-